INST HEPATITIS & VIRUS RES has a total of 32 patent applications. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are THERAVANCE BIOPHARMA R & D IP LLC, JANSSEN R & D IRELAND and SHANGHAI INST MATERIA MEDICA CAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | China | 8 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 3 | |
#5 | Canada | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Hong Kong | 1 | |
#8 | Israel | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Block Timothy M | 25 |
#2 | Xu Xiaodong | 22 |
#3 | Cuconati Andrea | 15 |
#4 | Guo Ju-Tao | 6 |
#5 | Birk Alexander V | 4 |
#6 | Du Yanming | 4 |
#7 | Dubovi Edward J | 4 |
#8 | Szeto Hazel H | 4 |
#9 | Xiao Tong | 3 |
#10 | Chang Jinhong | 3 |
Publication | Filing date | Title |
---|---|---|
CA2865962A1 | Inhibitors of hepatitis b virus covalently closed circular dna formation and their method of use | |
WO2013126640A2 | Benzodiazepine compounds with anti-flavivirus activity | |
CN103889953A | Sulfamoylbenzamide derivatives as antiviral agents against hbv infection | |
WO2012047856A2 | Novel inhibitors of secretion of hepatitis b virus antigens | |
US2011053141A1 | Methods for ultrasensitive detection and quantification of mutant hepatitis B viruses | |
CN102725417A | A lectin assay for assessing glycoforms as an early marker in disease | |
WO2010027996A1 | Novel imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity | |
CN101772347A | The 2-amino-2 of sense single stranded rna enveloped virus, the two deoxidation-α of 7--D-glycerol-D-glucose-pyrans heptose base inhibitor | |
WO2007131168A2 | Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus |